144 related articles for article (PubMed ID: 34643765)
1. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides.
Pompeia C; Frare EO; Peigneur S; Tytgat J; da Silva ÁP; de Oliveira EB; Pereira A; Kerkis I; Kolonin MG
J Mol Med (Berl); 2022 Jan; 100(1):65-76. PubMed ID: 34643765
[TBL] [Abstract][Full Text] [Related]
2. Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus.
Coronado MA; Gabdulkhakov A; Georgieva D; Sankaran B; Murakami MT; Arni RK; Betzel C
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):1958-64. PubMed ID: 24100315
[TBL] [Abstract][Full Text] [Related]
3. Biophysical and pharmacological characterization of a full-length synthetic analog of the antitumor polypeptide crotamine.
de Carvalho Porta L; Fadel V; D'Arc Campeiro J; Oliveira EB; Godinho RO; Hayashi MAF
J Mol Med (Berl); 2020 Nov; 98(11):1561-1571. PubMed ID: 32895732
[TBL] [Abstract][Full Text] [Related]
4. Structural and pharmacological characterization of the crotamine isoforms III-4 (MYX4_CROCu) and III-7 (MYX7_CROCu) isolated from the Crotalus durissus cumanensis venom.
Ponce-Soto LA; Martins-de-Souza D; Marangoni S
Toxicon; 2010 Jul; 55(8):1443-52. PubMed ID: 20206199
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of crotamine effects on mice hind limb paralysis employing both ex vivo and in vivo assays: Insights into the involvement of voltage-gated ion channels in the crotamine action on skeletal muscles.
Lima SC; Porta LC; Lima ÁDC; Campeiro JD; Meurer Y; Teixeira NB; Duarte T; Oliveira EB; Picolo G; Godinho RO; Silva RH; Hayashi MAF
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006700. PubMed ID: 30080908
[TBL] [Abstract][Full Text] [Related]
6. Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating properties.
Rádis-Baptista G; Kerkis I
Curr Pharm Des; 2011 Dec; 17(38):4351-61. PubMed ID: 22204433
[TBL] [Abstract][Full Text] [Related]
7. Quantification of crotamine, a small basic myotoxin, in South American rattlesnake (Crotalus durissus terrificus) venom by enzyme-linked immunosorbent assay with parallel-lines analysis.
Oguiur N; Camargo ME; da Silva AR; Horton DS
Toxicon; 2000 Mar; 38(3):443-8. PubMed ID: 10669031
[TBL] [Abstract][Full Text] [Related]
8. Crotamine inhibits preferentially fast-twitching muscles but is inactive on sodium channels.
Rizzi CT; Carvalho-de-Souza JL; Schiavon E; Cassola AC; Wanke E; Troncone LR
Toxicon; 2007 Sep; 50(4):553-62. PubMed ID: 17588630
[TBL] [Abstract][Full Text] [Related]
9. Biophysical and biological properties of small linear peptides derived from crotamine, a cationic antimicrobial/antitumoral toxin with cell penetrating and cargo delivery abilities.
Dal Mas C; Pinheiro DA; Campeiro JD; Mattei B; Oliveira V; Oliveira EB; Miranda A; Perez KR; Hayashi MAF
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2340-2349. PubMed ID: 28888370
[TBL] [Abstract][Full Text] [Related]
10. New view on crotamine, a small basic polypeptide myotoxin from South American rattlesnake venom.
Oguiura N; Boni-Mitake M; Rádis-Baptista G
Toxicon; 2005 Sep; 46(4):363-70. PubMed ID: 16115660
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of a new crotamine-like peptide from Crotalus oreganus helleri on C2C12 and CHO cell lines, and ultrastructural changes on motor endplate and striated muscle.
Salazar E; Rodriguez-Acosta A; Lucena S; Gonzalez R; McLarty MC; Sanchez O; Suntravat M; Garcia E; Finol HJ; Giron ME; Fernandez I; Deba F; Bessac BF; Sánchez EE
Toxicon; 2020 Dec; 188():95-107. PubMed ID: 33065200
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom.
Calderón L; Lomonte B
Arch Biochem Biophys; 1998 Oct; 358(2):343-50. PubMed ID: 9784249
[TBL] [Abstract][Full Text] [Related]
13. Biological versatility of crotamine--a cationic peptide from the venom of a South American rattlesnake.
Kerkis I; Silva Fde S; Pereira A; Kerkis A; Rádis-Baptista G
Expert Opin Investig Drugs; 2010 Dec; 19(12):1515-25. PubMed ID: 21062230
[TBL] [Abstract][Full Text] [Related]
14. Chemical and functional homology of myotoxin a from prairie rattlesnake venom and crotamine from South American rattlesnake venom.
Cameron DL; Tu AT
Biochim Biophys Acta; 1978 Jan; 532(1):147-54. PubMed ID: 620050
[TBL] [Abstract][Full Text] [Related]
15. Crotamine: a novel cell-penetrating polypeptide nanocarrier with potential anti-cancer and biotechnological applications.
Hayashi MA; Oliveira EB; Kerkis I; Karpel RL
Methods Mol Biol; 2012; 906():337-52. PubMed ID: 22791447
[TBL] [Abstract][Full Text] [Related]
16. Amino acid sequence of a myotoxin from venom of the eastern diamondback rattlesnake (Crotalus adamanteus).
Samejima Y; Aoki Y; Mebs D
Toxicon; 1991; 29(4-5):461-8. PubMed ID: 1862521
[TBL] [Abstract][Full Text] [Related]
17. Tyr-->Trp-substituted peptide 115-129 of a Lys49 phospholipase A(2) expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect.
Lomonte B; Pizarro-Cerdá J; Angulo Y; Gorvel JP; Moreno E
Biochim Biophys Acta; 1999 Nov; 1461(1):19-26. PubMed ID: 10556485
[TBL] [Abstract][Full Text] [Related]
18. Distribution of (125)I-labeled crotamine in mice tissues.
Boni-Mitake M; Costa H; Vassilieff VS; Rogero JR
Toxicon; 2006 Oct; 48(5):550-5. PubMed ID: 16919696
[TBL] [Abstract][Full Text] [Related]
19. Crotamine Cell-Penetrating Nanocarriers: Cancer-Targeting and Potential Biotechnological and/or Medical Applications.
Hayashi MAF; Campeiro JD; Porta LC; Szychowski B; Alves WA; Oliveira EB; Kerkis I; Daniel MC; Karpel RL
Methods Mol Biol; 2020; 2118():61-89. PubMed ID: 32152971
[TBL] [Abstract][Full Text] [Related]
20. Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo.
Mora-Obando D; Fernández J; Montecucco C; Gutiérrez JM; Lomonte B
PLoS One; 2014; 9(10):e109846. PubMed ID: 25290688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
